Volume | 2 672 014 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 0,876381 | Bas Haut |
|||||
Minimum Bas | 0,80 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Sunshine Biopharma Inc | SBFM | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
0,8662 | 0,80 | 0,876381 | 0,8602 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
7 155 | 2 672 014 | US$ 0,8402744 | US$ 2 245 225 | - | 0,75 - 140,00 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
21:16:08 | 100 | US$ 0,850075 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
21,83M | 25,68M | - | 24,09M | -4,51M | -0,18 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Sunshine Biopharma
Date | Heure | Source | Titre |
---|---|---|---|
06/3/2024 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
05/3/2024 | 22:37 | Edgar (US Regulatory) | Form PRE 14C - Other preliminary information statements |
05/3/2024 | 22:05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
23/2/2024 | 22:03 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
21/2/2024 | 22:28 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
21/2/2024 | 14:24 | Edgar (US Regulatory) | Form PRE 14C - Other preliminary information statements |
16/2/2024 | 23:01 | Edgar (US Regulatory) | Form 8-K - Current report |
15/2/2024 | 17:39 | Edgar (US Regulatory) | Form 8-K - Current report |
14/2/2024 | 21:53 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
14/2/2024 | 17:18 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
13/2/2024 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
12/2/2024 | 22:05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
Forum Action Sunshine Biopharma
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Sunshine Biopharma Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 0,88 | 1,19 | 0,75 | 0,8969153 | 12 264 281 | -0,02993 | -3,40% |
1 mois | 10,85 | 12,40 | 0,75 | 5,29 | 12 262 273 | -10,00 | -92,17% |
3 mois | 25,00 | 25,00 | 0,75 | 7,90 | 27 259 114 | -24,15 | -96,60% |
6 mois | 29,43 | 32,00 | 0,75 | 8,06 | 12 864 908 | -28,58 | -97,11% |
1 an | 56,10 | 140,00 | 0,75 | 12,19 | 6 716 553 | -55,25 | -98,48% |
3 ans | 275,00 | 987,00 | 0,75 | 170,25 | 4 577 820 | -274,15 | -99,69% |
5 ans | 275,00 | 987,00 | 0,75 | 170,25 | 4 577 820 | -274,15 | -99,69% |